MSc in Biotherapeutics (subject to final approval)

The DCU MSc in Biotherapeutics (NFQ Level 9) is the first postgraduate programme in the world providing education and training specifically focusing on biotherapeutics across cancer, neuro, immune and cardiovascular diseases within a unique setting offering access to the core Microbial Bioprocess Engineering (MBF) and GMP-like Manufacturing facilities as well as the state-of-the-art facilities at National Institute for Bioprocessing Research and Training (NIBRT).

Multidisciplinary in nature, the programme will appeal to a wide range of candidates from across sectors who work with and/or are planning to work with biomedical therapeutics, including but not limited to life scientists, professionals from the Biopharma and BioPharmaceutical, Biotechnology, Diagnostics and/or Healthcare industries, and medical practitioners (including GPs, clinicians-in-training, and specialist nurses). Graduates will be well placed to provide practice, professional leadership, innovation and scholarship expertise to a vast array of organisations to make a difference in the development and application of biotherapeutics.

The programme will be offered on both a part-time and a full-time basis, with the first intake commencing in September 2023 (subject to accreditation).